|
Contents
|
|
|
|
Cancer
Research |
|
|
|
Desser L,
Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I
Oral
therapy with proteolytic enzymes decreases excessive TGF-beta levels in human
blood
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S10-5
|
|
Gerard G.
Anticancer
treatment and bromelains
Agressologie 1972;13(4):261-74
|
|
Maurer HR
Bromelain:
biochemistry, pharmacology and medical use
Cell Mol
Life Sci. 2001 Aug;58(9):1234-45
|
|
Taussig SJ,
Batkin S
Bromelain,
the enzyme complex of pineapple (Ananas comosus) and its clinical application. An
update
J Ethnopharmacol 1988
Feb-Mar;22(2):191-203
|
|
Taussig
SJ, Szekerczes J, Batkin S
Inhibition
of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas
comosus)
Planta Med 1985 Dec;(6):538-9
|
|
Vellini M, Desideri D, Milanese A, Omini C, Daffonchio L,
Hernandez A, Brunelli G
Possible
involvement of eicosanoids in the pharmacological action of bromelain
Arzneimittelforschung 1986;36(1):110-2
|
|
|
Gliomas |
|
|
|
|
Fujita M, Kohanbash G, Fellows-Mayle W, Hamilton RL, Komohara Y, Decker SA,
Ohlfest JR, Okada H.
COX-2
blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor
cells.
Cancer Res. 2011 Feb 15. [Epub
ahead of print]
.JPG) Abstract |
.gif) Related articles
|
|
|
Sharma V, Dixit D, Ghosh S, Sen E.
COX-2
regulates the proliferation of glioma stem like cells.
Neurochem Int.
2011 Jul 7. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Temel
SG, Kahveci Z
Cyclooxygenase-2 expression in astrocytes and microglia in human
oligodendroglioma and astrocytoma
J Mol Histol. 2010 Jan 6;. [Epub ahead of print]
Abstract
|
|
Tysnes
BB, Maurer HR, Porwol T, Probst B, Bjerkvig R, Hoover F
Bromelain
reversibly inhibits invasive properties of glioma cells
Neoplasia 2001 Nov-Dec;3(6):469-79
Abstract | .png)
Reprint
| Related
articles
|
|
|
Xu
K, Gao H, Shu HK.
Celecoxib can induce vascular endothelial growth factor expression and tumor
angiogenesis.
Mol Cancer Ther. 2011 Jan;10(1):138-47.
Abstract |
Related articles
|
|
|
Medulloblastoma |
|
|
|
|
Baryawno N, Sveinbjörnsson B, Eksborg S, Orrego
A, Segerström L, Oqvist CO, Holm S, Gustavsson B, Kågedal B, Kogner P,
Johnsen JI.
Tumor-growthpromoting cyclooxygenase-2 prostaglandin E2 pathway provides
medulloblastoma therapeutic targets
Neuro Oncol. 2008
Aug 20. [Epub ahead of print]
Abstract
|
|
|
Monograph |
|
|
|
Barrie Cassileth
and K. Simon Yeung
Bromelain
(Sulphydryl proteolytic enzyme, cysteine-proteinase)
11/07/2002
Memorial Sloar-Kettering Cancer Center (HTML Full Text)
|
|
|
Non-Neoplastic
Diseases |
|
|
|
Masson
M.
Bromelain
in blunt injuries of the locomotor system. A study of observed applications in
general practice
Fortschr Med 1995 Jul 10;113(19):303-6
|
|
|
Non-CNS Tumors |
|
|
|
Beuth J, Ost
B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, Schneider B
Impact
of complementary oral enzyme application on the postoperative treatment results
of breast cancer patients--results of an epidemiological multicentre
retrolective cohort study
Cancer Chemother
Pharmacol 2001 Jul;47 Suppl:S45-54
|
|
Eckert K,
Grabowska E, Stange R, Schneider U, Eschmann K, Maurer HR
Effects
of oral bromelain administration on the impaired immunocytotoxicity of
mononuclear cells from mammary tumor patients
Oncol Rep 1999 Nov-Dec;6(6):1191-9
|
|
Gujral MS,
Patnaik PM, Kaul R, Parikh HK, Conradt C, Tamhankar CP, Daftary GV
Efficacy
of hydrolytic enzymes in preventing radiation therapy-induced side effects in
patients with head and neck cancers
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S23-8
|
|
Kaul R,
Mishra BK, Sutradar P, Choudhary V, Gujral MS
The
role of Wobe-Mugos in reducing acute sequele of radiation in head and neck
cancers--a clinical phase-III randomized trial
Indian J Cancer 1999 Jun-Dec;36(2-4):141-8
|
|
Popiela
T, Kulig J, Hanisch J, Bock PR
Influence
of a complementary treatment with oral enzymes on patients with colorectal
cancers--an epidemiological retrolective cohort study
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S55-63
|
|
